menu
    • menu

    Company profile for Virion Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Virion Therapeutics, LLC, is a science driven company developing innovative immune-based treatments for virally-associated cancers and chronic viral infections. Our vaccines, ChiVax and ChiVax-gD, represent novel and highly effective platforms to induce potent and sustained T cell-mediated immune responses against transformed or infected cells, thereby allowing us to target common diseases with unmet medical needs. Each compo...
    Virion Therapeutics, LLC, is a science driven company developing innovative immune-based treatments for virally-associated cancers and chronic viral infections. Our vaccines, ChiVax and ChiVax-gD, represent novel and highly effective platforms to induce potent and sustained T cell-mediated immune responses against transformed or infected cells, thereby allowing us to target common diseases with unmet medical needs. Each component comprising our chimeric vaccine candidates has completed pre-clinical testing that allow for their translation into clinical trials for a number of different indications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Virion TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Virion Therapeutics, LLC 7 Creek Bend Court, Newark DE USA 19711
    Telephone
    Telephone
    +800-841-9303
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.viriontx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Virion Shows Sustained HBsAg Decline After Single VRON-0200 Dose
    Virion Shows Sustained HBsAg Decline After Single VRON-0200 Dose

    09 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251109380893/en/Virion-Therapeutics-Reports-Progress-Towards-HBV-Functional-Cure-with-Sustained-and-Continued-HBsAg-Declines-up-to-One-Year-After-a-Single-VRON-0200-Dose-From-its-Phase-1b-Study-at-AASLDs-The-Liver-Meeting-2025

    BUSINESSWIRE
    09 Nov 2025
    Share Share
    Virion To Present HBV Functional Cure Data From VRON-0200 Study
    Virion To Present HBV Functional Cure Data From VRON-0200 Study

    07 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-07/virion-therapeutics-announces-upcoming-clinical-presentation-highlighting-vron-0200-study-progress-t

    PHARMIWEB
    07 Oct 2025
    Share Share
    Virion Therapeutics Reports Positive Clinical Data with VRON-0200
    Virion Therapeutics Reports Positive Clinical Data with VRON-0200

    28 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/virion-therapeutics-reports-positive-clinical-data-with-vron-0200-a-novel-checkpoint-modifier-for-hbv-functional-cure-at-apasl-2025-global-liver-meeting-302413448.html

    PR NEWSWIRE
    28 Mar 2025
    Share Share
    Virion Completes Enrollment of Phase 1b Chronic Hepatitis B Trial
    Virion Completes Enrollment of Phase 1b Chronic Hepatitis B Trial

    10 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/virion-therapeutics-completes-enrollment-of-first-2-cohorts-of-phase-1b-chronic-hepatitis-b-trial-of-vron-0200-for-hbv-functional-cure-302348218.html

    PR NEWSWIRE
    10 Jan 2025
    Share Share
    Virion Reports Clinical Responses with VRON-0200 at AASLD 2024
    Virion Reports Clinical Responses with VRON-0200 at AASLD 2024

    19 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/virion-therapeutics-reports-first-ever-clinical-responses-with-vron-0200-a-novel-checkpoint-modifier-for-hbv-functional-cure-at-aaslds-the-liver-meeting-302304358.html

    PR NEWSWIRE
    19 Nov 2024
    Share Share
    Ocean Bio: JV Partner Virion's VRON-0200 Shows Positive HBV Immunogenicity
    Ocean Bio: JV Partner Virion's VRON-0200 Shows Positive HBV Immunogenicity

    05 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/05/2893749/0/en/Ocean-Biomedical-NASDAQ-OCEA-Congratulates-Joint-Venture-Partner-Virion-Therapeutics-on-Positive-Immunogenicity-Results-from-Their-Lead-Checkpoint-Modifier-Containing-Immunotherapy.html

    GLOBENEWSWIRE
    05 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search